Evidence map›Paper›PMID 20826131›Full record

ArticleEuropean journal of pharmacology2010

Sustained morphine treatment augments prostaglandin E2-evoked calcitonin gene-related peptide release from primary sensory neurons in a PKA-dependent manner.

Suneeta Tumati, William R Roeske, Todd W Vanderah, Eva V Varga

Open access · greenAbstract read
In one paragraph

Article in European journal of pharmacology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Tissue Regeneration: The Dark Side of Opioids.International journal of molecular sciences · 2021
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. The Benzimidazole Derivatives, B1 (Frontiers in neuroscience · 2019
    Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Suneeta TumatiDepartment of Pharmacology, The University of Arizona, Tucson, AZ 85724, USA.
William R Roeske
Todd W Vanderah
Eva V Varga
University of Arizona · US

Funding

THERAPEUTIC PROFILES OF OPIOID DELTA RECEPTORS--NEW MODALITIESP01DA006284 · NIDA · UNIVERSITY OF ARIZONA · PI HRUBY, VICTOR J · 1989 to 2015
$14.8M
MOLECULAR MECHANISM OF ADENYLYL CYCLASE SUPERACTIVATIONR01GM065465 · NIGMS · UNIVERSITY OF ARIZONA · PI YAMAMURA, HENRY I · 2003 to 2006
$1.1M
NIDA NIH HHS DA 06284NIDA NIH HHS P01 DA006284NIGMS NIH HHS GM 065465NIGMS NIH HHS R01 GM065465
6 · The paper itself

Abstract

Tissue damage leads to pain sensitization due to peripheral and central release of excitatory mediators such as prostaglandin E₂ (PGE₂). PGE₂ sensitizes spinal pain neurotransmitter such as calcitonin gene-related peptide (CGRP) release via activation of cyclic AMP (cAMP)/protein kinase A (PKA)-dependent signaling mechanisms. Our previous data demonstrate that sustained morphine pretreatment sensitizes adenylyl cyclase(s) (AC) toward the direct stimulator, forskolin, in cultured primary sensory neurons (AC superactivation). In the present work we investigated the hypothesis that morphine pretreatment also sensitizes ACs toward Gs-protein-coupled excitatory modulators (such as PGE₂), leading to augmented PKA-dependent CGRP release from PGE₂-stimulated primary sensory dorsal root ganglion (DRG) neurons. Our results show that sustained morphine treatment potentiated PGE₂-mediated cAMP formation and augmented PGE₂-evoked CGRP release from cultured primary sensory neurons in a PKA-dependent manner. Our data suggest that attenuation of AC superactivation in primary sensory neurons may prevent the development of opioid-induced hyperalgesia.

Indexed as

AnimalsCalcitonin Gene-Related PeptideCell DifferentiationCyclic AMPCyclic AMP-Dependent Protein KinasesDinoprostoneDose-Response Relationship, DrugDrug SynergismGanglia, SpinalGene Expression RegulationIntracellular SpaceMorphineNeurotransmitter AgentsPainProtein Kinase InhibitorsRatsCalcitonin Gene-Related PeptideCyclic AMPCyclic AMP-Dependent Protein KinasesDinoprostoneMorphineNeurotransmitter AgentsProtein Kinase InhibitorsReceptors, Calcitonin Gene-Related PeptideReceptors, Prostaglandin E, EP2 SubtypeReceptors, Prostaglandin E, EP4 Subtype

Identifiers

PMID20826131
PMCPMC2955884
OpenAlexW2000423335

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.